These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 12871140)
1. Preterm labour: an overview of current and emerging therapeutics. Schwarz MK; Page P Curr Med Chem; 2003 Aug; 10(15):1441-68. PubMed ID: 12871140 [TBL] [Abstract][Full Text] [Related]
2. Update on tocolytic therapy. McCombs J Ann Pharmacother; 1995 May; 29(5):515-22. PubMed ID: 7655136 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of preterm labor. Caritis SN; Edelstone DI; Mueller-Heubach E Am J Obstet Gynecol; 1979 Mar; 133(5):557-78. PubMed ID: 35978 [TBL] [Abstract][Full Text] [Related]
6. Preterm labour management--an evidence--update. Piyamongkol W J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S154-7. PubMed ID: 21213513 [TBL] [Abstract][Full Text] [Related]
7. Prevention of preterm labour: 2011 update on tocolysis. Hubinont C; Debieve F J Pregnancy; 2011; 2011():941057. PubMed ID: 22175022 [TBL] [Abstract][Full Text] [Related]
8. Tocolytic treatment for the management of preterm labour: a systematic review. Tan TC; Devendra K; Tan LK; Tan HK Singapore Med J; 2006 May; 47(5):361-6. PubMed ID: 16645683 [TBL] [Abstract][Full Text] [Related]
9. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers. Kim A; Shim JY BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin endoperoxide H synthase inhibitors and other tocolytics in preterm labour. Mitchell BF; Olson DM Prostaglandins Leukot Essent Fatty Acids; 2004 Feb; 70(2):167-87. PubMed ID: 14683691 [TBL] [Abstract][Full Text] [Related]
11. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Higby K; Xenakis EM; Pauerstein CJ Am J Obstet Gynecol; 1993 Apr; 168(4):1247-56; discussion 1256-9. PubMed ID: 8097367 [TBL] [Abstract][Full Text] [Related]
12. Update on tocolytic therapy in the management of preterm labor. Givens SR J Perinat Neonatal Nurs; 1988 Jul; 2(1):21-32. PubMed ID: 2898017 [No Abstract] [Full Text] [Related]
13. Recent pharmacological advances in the treatment of preterm membrane rupture, labour and delivery. Doggrell SA Expert Opin Pharmacother; 2004 Sep; 5(9):1917-28. PubMed ID: 15330729 [TBL] [Abstract][Full Text] [Related]
14. Treatment of preterm labour. A review of the therapeutic options. Caritis SN Drugs; 1983 Sep; 26(3):243-61. PubMed ID: 6137355 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. Worldwide Atosiban versus Beta-agonists Study Group BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112 [TBL] [Abstract][Full Text] [Related]
17. Risk-benefit effects of tocolytic therapy. Pryde PG; Janeczek S; Mittendorf R Expert Opin Drug Saf; 2004 Nov; 3(6):639-54. PubMed ID: 15500422 [TBL] [Abstract][Full Text] [Related]
18. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women. Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630 [TBL] [Abstract][Full Text] [Related]
19. A risk-benefit assessment of therapies for premature labour. Higby K; Suiter CR Drug Saf; 1999 Jul; 21(1):35-56. PubMed ID: 10433352 [TBL] [Abstract][Full Text] [Related]
20. An update on the controversies of tocolytic therapy for the prevention of preterm birth. Ingemarsson I; Lamont RF Acta Obstet Gynecol Scand; 2003 Jan; 82(1):1-9. PubMed ID: 12580832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]